Robbins Andrew R has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 185000 shares of Cogent Biosciences, Inc. ($COGT) on December 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robbins Andrew R | President and CEO | A | Common Stock | 185000 | $0.00 | 185,000.0000 | 142,376,529 | 9999.99% | 0.13% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robbins Andrew R | President and CEO | A | Common Stock | 840000 | $0.00 | 1,025,000.0000 | 142,376,529 | 454.05% | 0.59% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robbins Andrew R | President and CEO | F | Common Stock | 367497 | $39.45 | 657,503.0000 | 142,376,529 | 35.85% | 0.26% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robbins Andrew R | President and CEO | A | Stock Option (Right to Buy) | 245000 | $0.00 | 245,000.0000 | 142,376,529 | 9999.99% | 0.17% |
| Jan. 23, 2025 | Cogent Biosciences, Inc. | $COGT | Robbins Andrew R | President and CEO | A | Stock Option (Right to Buy) | 915000 | $0.00 | 915,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Cogent Biosciences, Inc. | $COGT | Robbins Andrew R | President and CEO | A | Stock Option (Right to Buy) | 1100000 | $0.00 | 1,100,000.0000 | 0 | 9999.99% | 0.00% |